28
Oct
2025

Coriolis Pharma Research GmbH

Exhibitor at CPHI Frankfurt 2025 stand 6.0C50, Contract Manufacturing and Services
About Us

Coriolis Pharma is a globally operating contract research and development organization (CRDO) and the premier partner for drug product development, analytical, and manufacturing services across a vast array of therapeutic modalities.
Our expert scientists design and execute our platform and custom services to accelerate and derisk your program right from the start and throughout the entire product lifecycle.

We provide cutting-edge formulation technologies and state-of-the-art analytical methods and we support you from early development to commercialization.

  • DE
  • 2022
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.0C50, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Drug Product Development

    Product Drug Product Development

    We support our clients from early-stage research and preclinical phase to and beyond market approval by providing comprehensive development services, including 

    • Developability assessment • Pre-formulation screening • Formulation development • Lyophilization process development • Forced d...
  • Analytical Services (GMP and R&D)

    Product Analytical Services (GMP and R&D)

    Our analytical portfolio comprises 200+ different techniques – all performed by Coriolis’ experts in-house. Our offering includes:
    • Aggregate analytics • Particle characterization • Particle identification • Surfactant characterization • Higher order structure analysis • Funcional assays • Chemi...
  • Manufacturing Services

    Product Manufacturing Services

    We support our clients with the production of non-GMP drug product batches for preclinical and indicative stability studies, including
    • Liquid drug product manufacturing • Lyophilized drug product manufacturing • Analytics and stability testing